Skip to content

Use of Decision Support in the Management of Labour

A Multicentre Randomised Controlled Trial of an Intelligent System to Support Decision Making in the Management of Labour Using the Cardiotocogram

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02010710
Acronym
INFANT
Enrollment
47062
Registered
2013-12-13
Start date
2010-01-06
Completion date
2014-05-31
Last updated
2018-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal Intrauterine Distress First Noted During Labor and or Delivery in Liveborn Infant, Possible, Team Based on Their Existing Guidelines and the Woman Consents to Have EFM and EFM is

Keywords

continuous electronic fetal monitoring, labour, pregnancy, fetal distress

Brief summary

In women judged to require continuous electronic fetal heart rate monitoring (EFM) during their labour, does the addition of decision support software to aid the interpretation of the intrapartum cardiotocogram (CTG) reduce the number of 'poor neonatal outcomes'? This study is not introducing a new form of labour monitoring; it is evaluating the addition of decision-support to CTGs displayed on the Guardian™ system. Specifically comparing: No decision-support - CTGs with no additional interpretation (UK standard care), compared with: Decision-support - CTGs with the decision support software running that will alert clinicians to the presence of abnormalities in the CTG in real time. How the labour is managed is entirely up to the recruiting unit and the woman; however the allocation of decision-support or no decision-support is determined randomly by the Guardian™ system.

Interventions

DEVICEINFANT software

The decision-support software to be evaluated in INFANT has been designed to run on the K2 data collection system (Guardian®). The data collection system (Guardian®) is a system for managing information from labour monitoring. It displays the CTG on a computer screen alongside other clinical data which are collected as part of routine clinical care. As such, it replaces conventional paper labour notes, the CTG machine and other recording systems for documenting care during labour.

Sponsors

University of Oxford
CollaboratorOTHER
University of Birmingham
CollaboratorOTHER
University of Plymouth
CollaboratorOTHER
University of Leicester
CollaboratorOTHER
National Childbirth Trust
CollaboratorUNKNOWN
K2 Medical Systems
CollaboratorUNKNOWN
University College, London
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Require continuous electronical fetal monitoring during labour * they have a singleton or twin pregnancy * they are ≥ 35 weeks' gestation (≥ 245 days) * there is no known gross fetal abnormality, including any known fetal heart arrhythmia such as heart block * they are 16 years of age or older * they are able to give consent to participate in the trial as judged by the attending clinicians.

Exclusion criteria

* • triplets or higher order pregnancy * criteria for EFM not met, including elective caesarean section prior to the onset of labour

Design outcomes

Primary

MeasureTime frameDescription
Admissions to higher level of carewithin 48 hours and for longer than 48 hoursA composite of 'poor perinatal outcome' to include (a) all deaths (intrapartum stillbirths plus neonatal deaths i.e. deaths up to 28 days after birth) except deaths due to congenital anomalies, (b) significant morbidity: neonatal encephalopathy (moderate and severe); (c) admissions to the neonatal unit within 48 hours of birth for ≥ 48 hrs with evidence of feeding difficulties, respiratory illness or encephalopathy.

Secondary

MeasureTime frameDescription
Neuro Development2 yearsPARCA-R composite score at the age of two years

Other

MeasureTime frameDescription
Infant outcomesduring admission and at 2 years* Metabolic acidosis defined as a cord-artery pH \<7.05 (this is 2 standard deviations below the mean) with base deficit ≥ 12 mmol/l (this is a threshold above which the risks of neurological damage increase) * The distribution of cord-blood gas data for cord-artery pH * Apgar score \<4 at 5 minutes * Intrapartum stillbirth * Neonatal death * Seizures * Resuscitation interventions * Admissions to neonatal unit within 48 hours of birth for at least 48 hours * Admissions to neonatal unit within 48 hours of birth for at least 48 hours with evidence of: * Encephalopathy * Feeding difficulties * Respiratory illness * Admission to a higher level of care * In the sub-set of 7,000 surviving children without any degree of encephalopathy and agreed to be followed-up at age 2 years: * PARCA-R composite score * Cerebral palsy - (determined by asking the parents if their child has Cerebral palsy) * Late deaths (after the neonatal period) * General health issues at 2 years
Motherduring admission* Mode of delivery * Any operative intervention (caesarean section and instrumental delivery) for i. fetal distress, or ii. failure to progress, or iii. combination of fetal distress and failure to progress iv. other reason * Any episode of fetal blood sampling * Episiotomy * Grade of caesarean section * Length of first stage, length of second stage, total length of labour from trial entry

Countries

Ireland, United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026